XOMA Royalty Corporation
XOMAP
$24.97+0.00%
Delayed · as of Sep 15, 2026, 10:30 AM ET
Mkt cap
N/A
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$52.15M
EPS (9mo ended 2025-09-30)
$1.00
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
60.81%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported XOMAP revenue for 2025-12-31 was $52.1M. Net income was $31.7M. Revenue was up 83.1% from 2024-12-31 to 2025-12-31.
Use this XOMAP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full XOMAP income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
XOMA Royalty Corporation (XOMAP) is a biotechnology company in the Healthcare sector.
Latest cached XOMA Royalty Corporation (XOMAP) revenue for Dec 31, 2025 was $52.1M. Net income was $31.7M. Statements: https://lician.com/financials/xomap
XOMA Royalty Corporation (XOMAP) cached previous close $24.97; day range $24.97 – $24.97; volume 359. Session quote: https://lician.com/quote/xomap